Literature DB >> 14686970

Treatment of patch-stage mycosis fungoides with topical corticosteroids.

Herschel S Zackheim1.   

Abstract

Experience at the University of California, San Francisco (UCSF), in the management of patch-stage mycosis fungoides (MF) with topical, predominantly high-potency, corticosteroids is reviewed. The technique of applications is discussed in detail. Approximately 200 patients have been treated. The results are very favorable. The response rate is over 90%. Side-effects are minor. Topical clobetasol is the first-line treatment for early stage MF at UCSF.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14686970     DOI： 10.1111/j.1396-0296.2003.01639.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  8 in total

Review 1.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

2.  Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides.

Authors:  John T O'Malley; Adele de Masson; Elizabeth L Lowry; Anita Giobbie-Hurder; Nicole R LeBoeuf; Cecilia Larocca; Ahmed Gehad; Edward Seger; Jessica E Teague; David C Fisher; Thomas S Kupper; Phillip M Devlin; Rachael A Clark
Journal:  Clin Cancer Res       Date:  2019-10-21       Impact factor: 12.531

Review 3.  How to Sequence Therapies in Mycosis Fungoides.

Authors:  Caitlin M Brumfiel; Meera H Patel; Pranav Puri; Jake Besch-Stokes; Scott Lester; William G Rule; Nandita Khera; Jason C Sluzevich; David J DiCaudo; Nneka Comfere; N Nora Bennani; Allison C Rosenthal; Mark R Pittelkow; Aaron R Mangold
Journal:  Curr Treat Options Oncol       Date:  2021-09-27

4.  Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Authors:  Janet Y Li; Steven Horwitz; Alison Moskowitz; Patricia L Myskowski; Melissa Pulitzer; Christiane Querfeld
Journal:  Cancer Manag Res       Date:  2012-03-12       Impact factor: 3.989

5.  Cost of early-stage mycosis fungoides treatments in Spain.

Authors:  Pablo Luis Ortiz-Romero; Octavio Servitje; María Teresa Estrach; Rosa María Izu-Belloso; Ricardo Fernández-de-Misa; Fernando Gallardo; Noemí López-Martínez; Alejandro Pérez-Mitru
Journal:  Clinicoecon Outcomes Res       Date:  2020-02-12

Review 6.  T-cell lymphomas, a challenging disease: types, treatments, and future.

Authors:  Helen Ma; Maher Abdul-Hay
Journal:  Int J Clin Oncol       Date:  2016-10-14       Impact factor: 3.402

7.  Diagnostic Outcomes and Treatment Modalities in Patients with Mycosis Fungoides in West Sweden-A Retrospective Register-Based Study.

Authors:  Karolina Wojewoda; Martin Gillstedt; Hanna Englund; Shada Ali; Catharina Lewerin; Amra Osmancevic
Journal:  Cancers (Basel)       Date:  2022-09-25       Impact factor: 6.575

8.  A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)-A Retrospective Cohort Study.

Authors:  Christiane Querfeld; Theresa Pacheco; Bradley Haverkos; Gary Binder; James Angello; Brian Poligone
Journal:  Front Med (Lausanne)       Date:  2021-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.